These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 2938944
1. In vitro activity of the aryl-fluoroquinolones A-56619 and A-56620 and evaluation of disk susceptibility tests. Barry AL, Jones RN, Thornsberry C, Ayers LW, Gavan TL, Gerlach EH. Eur J Clin Microbiol; 1986 Feb; 5(1):18-22. PubMed ID: 2938944 [Abstract] [Full Text] [Related]
10. In vitro activity of CP-74667 compared with four other fluoroquinolones. Jones RN, Erwin ME. Diagn Microbiol Infect Dis; 1992 Aug; 15(6):531-6. PubMed ID: 1330419 [Abstract] [Full Text] [Related]
12. Studies to optimize the in vitro testing of piperacillin combined with tazobactam (YTR 830). Jones RN, Barry AL. Diagn Microbiol Infect Dis; 1989 Aug; 12(6):495-510. PubMed ID: 2560422 [Abstract] [Full Text] [Related]
18. Interpretive criteria for CI-960 (AM-1091, PD127391) disk diffusion tests using 5-microgram disks. Jones RN, Erwin ME, Barrett MS. Diagn Microbiol Infect Dis; 1992 Aug; 15(4):379-81. PubMed ID: 1319303 [Abstract] [Full Text] [Related]
19. Reevaluations of disk diffusion susceptibility testing interpretive criteria for lomefloxacin and norfloxacin using fluoroquinolone-resistant isolates. Cormican MG, Jones RN. Diagn Microbiol Infect Dis; 1995 Apr; 21(4):227-30. PubMed ID: 7554807 [Abstract] [Full Text] [Related]
20. In vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620 compared to that of other antimicrobial agents. Hirschhorn L, Neu HC. Chemotherapy; 1987 Apr; 33(1):28-39. PubMed ID: 3549179 [Abstract] [Full Text] [Related] Page: [Next] [New Search]